Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sakshi Tomar

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The Journal of Biological Chemistry|June 10, 2015
Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALSSakshi Tomar, Melanie L Johnston, Sarah E St John, et al.
Mbio|November 8, 2018
The Cellular NMD Pathway Restricts Zika Virus Infection and Is Targeted by the Viral Capsid ProteinKrystal A Fontaine, Kristoffer E Leon, Mir M Khalid, et al.
Bioorganic & Medicinal Chemistry Letters|October 2, 2013
Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit bindingMark Turlington, Aspen Chun, Sakshi Tomar, et al.
Journal of Medicinal Chemistry|December 13, 2012
Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV) 3CL proteaseJon Jacobs, Valerie Grum-Tokars, Ya Zhou, et al.
Plos Pathogens|January 5, 2023
Nuclear accumulation of host transcripts during Zika Virus InfectionKristoffer E Leon, Mir M Khalid, Ryan A Flynn, et al.
Mbio|March 27, 2014
A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variantSudhakar Agnihothram, Boyd L Yount, Eric F Donaldson, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The Journal of Biological Chemistry|June 10, 2015
Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALSSakshi Tomar, Melanie L Johnston, Sarah E St John, et al.
Mbio|November 8, 2018
The Cellular NMD Pathway Restricts Zika Virus Infection and Is Targeted by the Viral Capsid ProteinKrystal A Fontaine, Kristoffer E Leon, Mir M Khalid, et al.
Bioorganic & Medicinal Chemistry Letters|October 2, 2013
Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit bindingMark Turlington, Aspen Chun, Sakshi Tomar, et al.
Journal of Medicinal Chemistry|December 13, 2012
Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV) 3CL proteaseJon Jacobs, Valerie Grum-Tokars, Ya Zhou, et al.
Plos Pathogens|January 5, 2023
Nuclear accumulation of host transcripts during Zika Virus InfectionKristoffer E Leon, Mir M Khalid, Ryan A Flynn, et al.
Mbio|March 27, 2014
A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variantSudhakar Agnihothram, Boyd L Yount, Eric F Donaldson, et al.
Pageof 2